Two newly identified factors may raise the lifetime risk of symptomatic OA that requires total hip arthroplasty.
Mariah Zebrowski Leach, JD, MS
A wish list from your patients with rheumatoid arthritis who are—or who want to become—mothers.
Hyperuricemia remains the leading risk factor, but the runners-up may surprise you.
Here, insights from some experts on the patient’s experience of rheumatoid arthritis.
Various biologics that focus on the IL-17 pathway are currently being studied.
New data highlight the role of the C5a-C5aR axis in the onset of inflammation.
Recently published EULAR/ACR classification criteria generally perform better than previous criteria.
No differences were observed in patellofemoral joint morphology between asymptomatic patients and those with pain.
Mepolizumab gets the nod for the rare disease formerly known as Churg-Strauss syndrome.
A commonly held belief has been debunked.